Fetal Congenital Pulmonary Airway Malformation: Regression Versus Resection

Fetal congenital pulmonary airway malformation (CPAM), previously called congenital cystic adenomatoid malformation, is a developmental lesion in which abnormal lung tissue forms cysts or solid areas. It is usually detected during a routine second-trimester ultrasound, often before the pregnancy has produced any symptoms. The finding can create considerable uncertainty because some lesions become much smaller before birth, while others cause hydrops, mediastinal shift or breathing problems in the newborn.

The central decision is rarely as simple as choosing “observe” or “operate”. Clinicians assess the lesion’s size, appearance, blood supply, growth pattern and effect on the heart, lungs and amniotic fluid. The same scan may support expectant management in one pregnancy and prompt urgent intervention or planned neonatal surgery in another.

For families in Australia, care may involve a fetal medicine unit in Sydney, Melbourne, Brisbane, Perth or another tertiary centre, with ongoing coordination between local obstetricians, paediatric surgeons, neonatologists and diagnostic imaging teams. Long travel from regional areas, Medicare-funded public care, private obstetric services and state-based hospital pathways can all influence how surveillance and delivery are organised.

How CPAM Develops And Appears On Ultrasound

CPAM arises when part of the developing lower respiratory tract branches abnormally. The lesion may contain several large cysts, numerous small cysts, or a predominantly solid echogenic area. A systemic feeding artery from the thoracic or abdominal circulation may be visible on Doppler imaging, which helps distinguish CPAM from some other congenital lung lesions, including pulmonary sequestration.

Ultrasound follow-up is used to measure the lesion and evaluate its physiological effect. The congenital pulmonary airway malformation volume ratio, or CVR, compares the estimated lesion volume with fetal head circumference. A rising CVR, especially when accompanied by fluid around the fetus, skin oedema, ascites or cardiac compression, signals a higher risk of deterioration. MRI can add useful anatomical detail when ultrasound views are limited, although it does not replace serial sonography.

A large lesion can push the mediastinum away from the affected side and reduce the space available for normal lung growth. The appearance may change as pregnancy advances because the abnormal tissue can become less conspicuous relative to the growing fetus. That visual improvement should be interpreted alongside blood flow, amniotic fluid, fetal movement and signs of hydrops rather than treated as proof that the lesion has vanished.

What Prenatal Regression Really Means

Many CPAMs stabilise or appear to regress during the third trimester. In practical terms, “regression” generally means that the lesion becomes smaller in proportion to the fetus or is no longer clearly visible on ultrasound. It does not necessarily mean that all abnormal lung tissue has been eliminated. A residual lesion may still be found after birth, particularly on chest radiography, computed tomography or surgical pathology.

The likelihood of improvement varies with morphology. Macrocystic lesions can enlarge quickly if cysts fill with fluid, while microcystic or solid lesions may produce a greater mass effect earlier in gestation. Some lesions shrink after their growth peak, yet the normal lung may remain underdeveloped if compression was prolonged. The infant’s postnatal condition therefore matters as much as the late-pregnancy image.

Serial imaging is the safest way to establish a trend. A single scan can be misleading because fetal position, equipment, operator experience and changing cyst fluid affect apparent size. In Australia, a family living several hours from a tertiary centre may have scans coordinated between a regional hospital and a metropolitan fetal medicine service. Clear communication about which team reviews the images helps prevent delays or contradictory advice.

When Observation Is A Reasonable Choice

Expectant management is often appropriate when the fetus has no hydrops, the lesion is stable or regressing, the heart is not significantly compressed and amniotic fluid remains acceptable. Surveillance commonly includes ultrasound every one to four weeks, with the interval adjusted according to gestation, lesion behaviour and local protocol. Corticosteroids may be considered for selected high-risk microcystic lesions, particularly when there is concern about rapid growth or hydrops, although treatment decisions require specialist assessment.

The purpose of observation is active risk management, not passive inaction. Clinicians monitor fetal growth, cardiac function, lesion volume, mediastinal position and signs of fluid accumulation. Parents should receive a written plan identifying the warning findings that would change care, including a sudden increase in lesion size, reduced fetal movements or new evidence of hydrops.

Delivery planning is equally important. A stable pregnancy may proceed close to term, with birth arranged at a hospital that can provide neonatal respiratory support and rapid surgical review. Families may need to plan accommodation near a tertiary unit, time away from work and travel arrangements, especially when the closest paediatric surgical service is in a capital city. Telehealth can support consultations, but it cannot replace urgent in-person assessment when fetal or newborn deterioration is suspected.

Findings That Favour Fetal Intervention

Severe hydrops, persistent rapid growth, marked mediastinal shift and cardiac compromise are the principal concerns in a high-risk CPAM. In a macrocystic lesion, ultrasound-guided thoracoamniotic shunting may drain a dominant cyst and relieve pressure. This can improve venous return and reduce hydrops in carefully selected cases. A microcystic or predominantly solid lesion is less amenable to simple drainage.

Open fetal surgery or fetoscopic techniques are rare, highly specialised options reserved for exceptional circumstances. They carry significant risks, including preterm birth, membrane rupture, bleeding and maternal complications. Decisions are made by a multidisciplinary fetal therapy team after a detailed assessment of prognosis and alternatives. Discussion of complex fetal conditions can also benefit from experience gained in other high-risk pregnancies; for example, the principles of serial ultrasound, fluid assessment and coordinated counselling described in TTTS management updates illustrate why changing physiology must be followed over time rather than judged from one scan.

In Australia, access to fetal intervention is concentrated in a small number of tertiary hospitals. Referral pathways may differ between New South Wales, Victoria, Queensland, Western Australia and other jurisdictions. State and territory legislation also governs consent, privacy, pregnancy care and the circumstances in which particular interventions can be offered. Families should receive advice from the treating service about the relevant local requirements rather than relying on information from overseas websites.

Planning Birth And Newborn Assessment

A fetus with a small, stable CPAM may be delivered at term in a hospital with routine neonatal services, depending on the local plan. A large lesion, previous hydrops or suspected pulmonary hypoplasia usually supports birth at a tertiary perinatal centre. Vaginal birth is often possible when there is no obstetric indication for caesarean delivery. The mode and timing of birth should be based on maternal and fetal factors, not simply the presence of a lung lesion.

At birth, the neonatal team assesses respiratory effort, oxygenation, chest movement and haemodynamic stability. Symptomatic infants may need oxygen, ventilation, drainage of a large cyst or urgent surgical review. An infant who is clinically well may undergo delayed imaging and elective resection rather than immediate operation. Chest radiography, ultrasound, CT or MRI can define the residual abnormality and its relationship to normal lung.

The decision to remove a persistent CPAM is individualised. Surgery is strongly considered for recurrent respiratory symptoms, infection, significant residual disease, a lesion with concerning features or uncertainty about the diagnosis. Some surgeons favour elective lobectomy in an apparently well infant because it prevents future infection and removes tissue that could complicate later diagnosis. Others support careful surveillance in selected asymptomatic children, balancing operative risk against the possibility of future symptoms.

Resection, Recovery And Long-Term Outlook

When surgery is chosen, the common operation is removal of the affected lobe, usually through an open or thoracoscopic approach. Thoracoscopic lobectomy may reduce incision size and postoperative discomfort in suitable infants, although the best method depends on age, anatomy, surgeon experience and the child’s clinical condition. The abnormal tissue is sent for histopathology, which confirms the diagnosis and excludes alternative lesions.

Most children who have an isolated CPAM and adequate surrounding lung have a good outlook. The remaining lung can grow and compensate over time, particularly when the lesion has not caused severe prenatal compression or neonatal respiratory failure. Follow-up may include respiratory reviews, imaging, assessment of exercise tolerance and monitoring for recurrent infection. Parents should report persistent cough, wheeze, fever or poor weight gain after discharge.

Postnatal feeding support is part of recovery, especially after intensive care or thoracic surgery. Breastfeeding may be delayed by respiratory support, maternal separation, pain or fatigue, and families may need help with expressing and maintaining milk supply. Broader evidence about how health-system disruption affects feeding practices is discussed in this analysis of breastfeeding during COVID-19, a useful reminder that practical support can shape outcomes alongside medical treatment.

Making A Shared Decision In Australia

Parents usually need several conversations before deciding whether a regressing lesion should be observed or removed after birth. The discussion should cover the latest ultrasound findings, estimated risk of hydrops, likely delivery location, possible newborn respiratory needs and the advantages and disadvantages of early surgery. It should also explain what is known and unknown, because prenatal imaging cannot always predict the exact postnatal anatomy.

Australia’s public and private health systems may offer different pathways for scans, specialist consultations and elective surgery. Medicare can cover eligible medical services, while hospital admission, private insurance, travel and accommodation costs vary. The local market for paediatric surgical care is concentrated in major centres, so families in regional Australia may need assistance through state travel schemes or hospital social workers. Asking early about referral documentation, scan transfer and accommodation can reduce avoidable stress.

Consent should be informed, voluntary and revisited when the clinical picture changes. Families may request a second opinion from a fetal medicine specialist or paediatric thoracic surgeon, particularly when surgery is being considered for an asymptomatic newborn. The most appropriate plan is the one that matches the lesion’s behaviour, the baby’s condition, available expertise and the family’s informed values.

Fetal CPAM should therefore be viewed as a changing condition rather than a fixed diagnosis. Regression can lower risk without guaranteeing cure, while resection can provide certainty and prevent later complications at the cost of an operation. Close surveillance, timely referral and coordinated prenatal and neonatal care allow many Australian families to move from uncertainty to a carefully prepared birth and follow-up plan.

Families and clinicians can use each scan, consultation and newborn assessment to refine the decision. Request a coordinated review from a fetal medicine team and paediatric surgical service when the lesion persists, grows or produces pressure effects, and keep the written monitoring and birth plan accessible to everyone involved in care.